MyoKardia Analysis
MyoKardia is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of MyoKardia delisted stock analysis is to determine its intrinsic value, which is an estimate of what MyoKardia is worth, separate from its market price. There are two main types of MyoKardia's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect MyoKardia's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of MyoKardia's stock to identify patterns and trends that may indicate its future price movements.
The MyoKardia stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. MyoKardia is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. MyoKardia Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and MyoKardia's ongoing operational relationships across important fundamental and technical indicators.
MyoKardia |
MyoKardia Stock Analysis Notes
About 95.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 5.66. MyoKardia had not issued any dividends in recent years. MyoKardia, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. As of November 16, 2020, MyoKardia, Inc. operates as a subsidiary of Bristol-Myers Squibb Company. MyoKardia operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 318 people. To find out more about MyoKardia contact Tassos Gianakakos at 650 741-0900 or learn more at www.myokardia.com.MyoKardia Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. MyoKardia's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding MyoKardia or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| MyoKardia is not yet fully synchronised with the market data | |
| MyoKardia has some characteristics of a very speculative penny stock | |
| MyoKardia has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 12.4 M. Net Loss for the year was (276.96 M) with loss before overhead, payroll, taxes, and interest of (226.17 M). | |
| MyoKardia currently holds about 895.88 M in cash with (195.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 16.8. | |
| Over 95.0% of the company shares are owned by institutional investors |
MyoKardia Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 11.99 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MyoKardia's market, we take the total number of its shares issued and multiply it by MyoKardia's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.MyoKardia Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific MyoKardia insiders, such as employees or executives, is commonly permitted as long as it does not rely on MyoKardia's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases MyoKardia insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Wendy Yarno over a year ago Exercise or conversion by Wendy Yarno of 2300 shares of MyoKardia subject to Rule 16b-3 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding MyoKardia to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in MyoKardia Stock
If you are still planning to invest in MyoKardia check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MyoKardia's history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |